MIRA Pharmaceuticals Says 7-Day Repeated-Dose Dog Study Of Obesity Candidate SKNY-1 Showed Dose-Dependent Exposure, Supporting Advancement Toward GLP Toxicology, IND-Enabling Work

Loading news article.

MIRA Pharmaceuticals Says 7-Day Repeated-Dose Dog Study Of Obesity Candidate SKNY-1 Showed Dose-Dependent Exposure, Supporting Advancement Toward GLP Toxicology, IND-Enabling Work | WAPE

MIRA Pharmaceuticals Says 7-Day Repeated-Dose Dog Study Of Obesity Candidate SKNY-1 Showed Dose-Dependent Exposure, Supporting Advancement Toward GLP Toxicology, IND-Enabling Work

Article summary

Related companies

Comments —